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Abstract
Objective: Since the 1960s newborn screening (NBS) for several rare and serious disorders has
been in place across Australia. Testing of a simple blood spot now enables the early detection of
over 30 conditions. Policies across Australian states have diverged in some aspects of NBS,
especially in the retention and further use of dried blood spots collected as part of the screening
and attempts are underway to bring some further national consistency. Whilst this has initiated
debate amongst health professionals and policy makers there is limited empirical evidence of wider
community attitudes to such issues.
Methods: This research has explored the range and depth of views held by the wider community
in New South Wales through moderated small group discussions. It has also assessed the range and
depth of responses where the groups are reconvened after being given further information.
Results: The findings suggest that there is limited community awareness of the public health
importance of NBS and especially that resulting biological samples are stored. Members of the
wider community presented with opportunities to consider current procedures and policies
appear reassured and to have high levels of trust. However there are clearly some groups who have
concerns with the storage of dried blood spot specimens and perceive that these may be abused.
Policy implications and conclusion: The findings will inform health professionals and policy
makers as to the perceived benefits and future challenges NBS raises for the wider community. The
findings have implications for improving current communications about NBS, maintaining public
confidence and the development of state and national initiatives in genetic health.
Background
Newborn Screening (NBS) programs based upon blood
samples from newborn babies have been operating in
Australia since the late 1960s. The programs were initiated
by the development of a biochemical assay by Guthrie to
detect the chemical imbalances found in the blood of
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babies affected by phenylketonuria (PKU) [1]. Screening
was expanded to include testing for congenital hypothy-
roidism, galactosaemia and cystic fibrosis [2,3]. The intro-
duction in recent years of testing using Tandem Mass
Spectrometry (TMS) methods [4] has enabled the inclu-
sion of a much larger panel of conditions.
In the Australian state of New South Wales (NSW) the col-
lected newborn blood spots are currently screened for
about 30 conditions where early detection and treatment
can positively impact on the health of an affected child
and family. Annually about 85,000 babies born in NSW
[5] are screened and about 90 babies are diagnosed with
one of the screened conditions following a positive
screening test. The blood sample, taken by heel-prick 48–
72 hours after birth, is dried on cards originally known as
Guthrie cards but which are now more appropriately
referred to as dried blood spot specimens [6].
NSW Health policy [7] directs that informed verbal paren-
tal consent must be obtained before the procedure is car-
ried out. The policy also requires that information is
provided prior to testing in the form of a pamphlet [8]
and that discussion should take place between health pro-
fessionals and parents. It requires that consent is noted in
the medical record of the mother and or child. Most par-
ents do consent to screening and in cases where parents
refuse NBS, policy requires that refusal is recorded in the
mother's or baby's file. The parents are only informed of
the test results from NBS if the result indicates a problem
or further testing is required.
Screening programs in other Australian states have many
similarities to NSW although there are some differences
[2]. Whilst there has been some variation in the past as to
precisely what conditions are tested for these are now
essentially aligned apart from some technical differences
in biochemical testing methods and their implementa-
tion. Protocols for collecting verbal consent vary slightly
and there is also some variation in the content of educa-
tional information offered in advance to parents.
The clearest difference in approach has been in the reten-
tion policies for dried blood spot specimens which differ
significantly across Australian states. Some states retain
dried blood spot specimens indefinitely and others hold
them for just two years before they are destroyed [9]. In
NSW the dried blood spot specimens are stored for 18
years in a secure facility at the NBS Laboratory after which
time they are destroyed [7]. The development of a uni-
form approach to newborn screening has been recom-
mended by the Australian Law Reform Commission [9]
and has also received support from the Australian Govern-
ment [10].
The stored specimens may be used for quality assurance
and audit practices by the laboratory and for the develop-
ment of test protocols to further expand newborn screen-
ing. They may also be used, with the consent of parents,
for the medical benefit of the family such as enabling pre-
natal testing in future pregnancies where information
from an affected child is otherwise unavailable.
In addition, dried blood spot specimens may also be used
for Human Research Ethics Committee (HREC) approved
medical research [11]. Other uses include forensic testing.
A formal agreement between NSW Health and NSW
Police provides a protocol for police access to the speci-
mens as part of their investigations [12].
Approximately 400 dried blood spot specimens from
NSW have been used in the last 3 years for HREC
approved research and about ten dried blood spot speci-
mens since 2002 have been requested by the Police for the
identification of remains of a person (personal communi-
cation Bridget Wilcken, Director NBS laboratory, NSW).
While NBS programs have been operating in Australia for
over 40 years, the experiences, awareness, perceptions and
attitudes towards NBS amongst the wider community
have not been formally explored. In 2005 the Centre for
Genetics Education undertook such a study exploring
views about the program in NSW including the retention
and further use of the dried blood spot specimens.
This paper focuses on consumer awareness and under-
standing of NBS and in particular views towards the reten-
tion and further use of the specimens. Responses to issues
of consent, information provision and the potential to
further expand NBS are being reported separately.
Methods
A reconvened group discussion methodology, based upon
previous studies exploring public perceptions of medical
research [13], was used which allowed exploration of
both existing and more deliberated viewpoints. The
project and stimulus materials were developed with guid-
ance from an Expert Advisory Group (EAG) with experi-
ence of NBS, policy, health ethics and communications.
The research protocol was approved by the institution's
Human Research Ethics Committee.
Sample and recruitment
Discussions were undertaken with nine groups: 40 partic-
ipants in total, comprising 24 women and 16 men (Table
1). Groups were structured such that participants shared
similar socioeconomic backgrounds and were single sex
to promote the development of group dynamics. It was
intended to engage a cross section of distinct groups with
potentially different stakeholder perspectives of newbornAustralia and New Zealand Health Policy 2006, 3:14 http://www.anzhealthpolicy.com/content/3/1/14
Page 3 of 9
(page number not for citation purposes)
screening and the use of the stored dried blood spot spec-
imens. The groups included young adults whose dried
blood spot specimens had recently been destroyed,
recruited through youth agencies in regional NSW
(Groups 1–2); parents who had likely recently experi-
enced NBS, recruited through several Child Health Cen-
tres in suburban Northern and Western Sydney (Groups
3–5) and parents with older children where the child's
NBS died blood spots were being stored, recruited
through a professional market research field recruitment
agency in suburban Northern and Western Sydney
(Groups 6–9).
Participants were provided with refreshments, childcare
support where required and a $50 shopping voucher for
attending both sessions.
Discussion format
Each group met initially for about 90 minutes. Interviews
were conducted using an agreed topic guide and by pre-
senting stimulus materials intended to support further in-
depth discussion. The discussions about NBS were intro-
duced from a base of general health perceptions and infor-
mation sources which then moved to understanding of
the concepts of screening and testing in general. Whilst
the research approach and use of the stimulus materials
required some structure and order to the conversation, it
was also possible to consider issues as they were naturally
raised by participants.
Each group was reconvened between one and three weeks
later. All but two of the younger women in Group 1
attended the reconvened sessions. These sessions were
moderated in a less structured manner and focused upon
the issues that participants themselves raised after having
considered the issues and sought out the views of others
in the community. The intention here was to examine
how participants had considered the issues over time and
to what extent their views had developed. Emphasis was
placed upon discussions of the storage and further usage
of the dried blood spot specimens.
Simple stimulus materials were developed to provide
some focus for further discussion and deliberation around
newborn screening and storage of the blood spot speci-
mens. The materials covered current and potential future
NBS testing; consent procedures and policies; the storage
and further use of the dried blood spot specimens; and the
rules governing access to them. The information was pre-
sented as several show-cards which covered the informa-
tion contained in the NSW NBS pamphlet [8] in simple
bullet-point format. Additionally four short scenarios
were developed which were selected as examples covering
the range of issues under deliberation:
1. A mother whose child is diagnosed with PKU
2. A couple overseas whose child is diagnosed with Duch-
enne muscular dystrophy
3. A couple who have been asked to consent to the further
use of a stored dried blood spot specimen
4. A woman who wishes to access a dried blood spot spec-
imen in a paternity legal action.
Analysis
Group discussions were audio recorded and transcribed.
Where possible the individual speaking within a group
was identified in the transcript such that comments could
be followed through each session and used in the analysis.
Transcripts were analysed using a Framework methodol-
ogy [14] to identify and code common themes, using
Microsoft Excel spreadsheets which allowed cross tabula-
tion of individual responses against these themes. Where
necessary, further development and editing of themes
were undertaken during the coding process. Consistency
in coding was validated by the authors independently
coding several transcripts with differences discussed and
resolved.
Table 1: Sample Characteristics for Group Discussions
Group Gender No. Participants Age Youngest Child Area
1F8-R e g i o n a l  N S W
2M 3-N o r t h e r n  S y d n e y
3F4<  6  m o n t h s I n n e r  W e s t  S y d n e y
4M 3<  2  y e a r s N o r t h e r n  S y d n e y
5 F 3 < 6 months North West Sydney
6F45  – 1 8  y e a r s N o r t h e r n  S y d n e y
7M 55  – 1 8  y e a r s N o r t h  W e s t  S y d n e y
8F55  – 1 8  y e a r s I n n e r  W e s t  S y d n e y
9M 55  – 1 8  y e a r s I n n e r  W e s t  S y d n e yAustralia and New Zealand Health Policy 2006, 3:14 http://www.anzhealthpolicy.com/content/3/1/14
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Results
Exploring Newborn Screening
For most participants NBS was not a familiar term by itself
but they associated it with a number of newborn interven-
tions of which they had some experience. The concept was
also associated with other procedures such as vitamin K
injections and Hepatitis B vaccination. There was little
specific knowledge of protocols, procedures and rules
related to NBS.
The key trigger for most participants who recalled the test
was mention of the heel prick blood test rather than the
term 'Newborn Screening'. The heel prick was recalled by
most women with young babies and with older children
and was also reported by all the younger fathers; a few of
the fathers with older children also had quite distinct rec-
ollections of the test being done. In particular parents
recalled whether they had been present at the time of the
test and whether the baby cried after the heel prick.
Another common recollection was that this was the test
where parents were only informed of the results if there
was some problem.
Recollection of the heel prick was not generally linked to
an understanding of what specifically was being tested for
but this did not seem a cause of concern. One father who
had videotaped his child having a heel prick stated: "I
don't know what they test for. I know it's something good. It's
not bad" Group4a. Some participants suggested that the heel
prick was part of testing for conditions such as autism,
HIV, jaundice or blood clotting diseases. A few partici-
pants seemed more confident in their knowledge and
stated that the heel prick test was for cystic fibrosis. Two
individuals recalled that the test was in some way linked
to the "artificial sweetener condition" [PKU]Groups4a,5a. In
one case this information was gleaned from reading the
label on the can of a diet soft drink. The other participant
(a woman with several family members in the medical
profession) specifically mentioned that one of the condi-
tions included was called PKU and that individuals
affected needed to follow a special diet. NBS was generally
unfamiliar to the two groups of younger people (Groups
1–2) even when prompted by the term "heel prick".
Support for Newborn Screening
All participants were highly supportive of the principles of
current NBS as outlined in the show-card presented to
them. Early detection of a condition was a key positive
aspect for them. They knew little about the specific condi-
tions detected and were surprised to hear that as many as
30 different conditions could be detected by NBS. A few
participants were keen to have further information about
these other unfamiliar "alphabet diseases"  Group9a, Group9b
currently included in NBS. Participants often did not ini-
tially realise that many of the conditions detected were
inherited in families.
When presented with the first scenario which covered cur-
rent PKU screening their responses were overwhelmingly
positive. None of the participants raised personal or spe-
cific concerns with testing for PKU. Participants assumed
that almost all parents would see the value in screening
for such a treatable condition. Most also reacted positively
to the further expansion of screening to include additional
conditions, such as Duchenne muscular dystrophy, where
there are more limited, if any, options available. At the
same time, there was recognition of the impact of such an
early diagnosis on parenting and the family. Further anal-
ysis of the discussion surrounding the conditions
included in NBS and information provision is being sep-
arately reported.
Storage of the dried blood spot specimens
Participants were prompted to discuss their wider experi-
ence, knowledge and views towards healthcare related to
tissue and blood samples. Such understanding was lim-
ited, with almost all believing that such health samples
would be destroyed after initial testing. Common reasons
cited were that storage would serve no purpose; the sam-
ple is no longer needed; the patient can just give another
sample if it is necessary and the results are probably kept
but physical samples would be impractical to store. On
probing and with further reflection a few suggested that
there could be some value in storing certain samples,
especially tissue for further testing and medical research.
All participants were initially unaware that the dried
blood spot specimens, including those of their own chil-
dren, were being stored. When presented with this infor-
mation on a show-card, reactions included surprise,
curiosity and even shock. It immediately raised general
questions such as "What's the point of storing these blood
spots?", "Why the 18 years?" and "Wouldn't such widespread
storage be cumbersome?" Considering this new knowledge
that the dried blood spot specimens were stored led some
to begin considering what had happened to other health
samples that had been taken from them.
Participants also found that the friends and family with
whom they spoke between the discussion sessions were
equally unaware that the dried blood spot specimens were
kept. Only one participant found someone who was
already aware that they were stored: their partner had seen
a national television show that included some discussion
about the storage of the specimens. Almost all partici-
pants felt that it was vital for parents to know that the
dried blood spot specimens are stored for 18 years and
potentially used for various purposes.Australia and New Zealand Health Policy 2006, 3:14 http://www.anzhealthpolicy.com/content/3/1/14
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Using the dried blood spot specimens
When asked to further consider and speculate just why
they thought the dried blood spot specimens were stored,
unprompted responses included that they could be used
for quality assurance or re-testing. Some participants felt
they could be useful for the family to find a reason for an
illness that had later affected their child. Some considered
it would be possible to extract DNA from them. Others
had not previously made this link but as they considered
what they knew about DNA forensics from popular televi-
sion dramas it was clear to them this was indeed a possi-
bility.
(a) 'Family'
The possible use of the dried blood spot specimens by
families was often interpreted as parents being able to
access them at a later date for further health information
about their children. This included exceptional circum-
stances such as using them to later investigate why a child
had died.
More commonly there was the perception that the stored
specimens might provide some direct benefits to the child
or family. It was suggested that parents may desire further
tests on the specimens as their child grew up and that tak-
ing another blood sample from the child could be
avoided by accessing them. Concern was expressed
among some of the younger women whose specimens
had recently been destroyed that they would 'miss out' on
these perceived personal and family benefits.
(b) Medical research
Use in medical research was generally viewed support-
ively. It was widely agreed that parents should be
informed and consulted if identifying information would
be provided to researchers requesting the dried blood spot
specimens. The concept of research upon anonymised
samples was clearly grasped and seeking parental consent
in such cases only viewed as important by a few. A couple
of individuals in different groups came up with the sug-
gestion that the samples could be permanently ano-
nymised at 18 years by simply cutting off the identifying
information from the card and this could extend the life
of this apparently valuable research resource.
Unacceptable uses of the dried blood spot specimens for
research commonly included human cloning and any
research that might lead to discrimination by insurers or
employers. Some had strong views that access by pharma-
ceutical and biotechnology companies should be resisted,
views that were underpinned by a belief that health
research and developments should not be driven by a
profit principle. It was also argued that commercial com-
panies might bias or manipulate research findings. Such
suggestions prompted others to counter that advances in
health would not happen without such commercial
motives. The idea of more commercially oriented research
was often more palatable if there could be some clear
return of benefits to the community or public health sys-
tem.
Whilst participants generally agreed that there would be
some research areas and situations they would find prob-
lematic, they were generally prepared to let these deci-
sions lie with others representing the public good such as
research ethics committees. The concept and role of such
bodies was also easily grasped and even though little was
known about their workings a high level of trust and sup-
port was expressed for their judgments.
(c) Access by police and courts
Access to the samples by the police for identifying missing
persons and solving crimes was not controversial for
many participants and several saw considerable potential
value in the stored samples to identify missing children.
They cited media stories published during the fieldwork
period which documented attempts to identify a missing
child using DNA testing [15]. Popular television shows
focusing on forensics were often mentioned as a source of
knowledge about the use of DNA from blood samples in
identifying human remains, missing persons and in solv-
ing crimes.
Several participants also viewed positively the potential to
use the dried blood spot specimens in some manner to
identify a suspect in a crime and for many it was a case of
"if you have nothing to hide what would the problem be?" Group
3b. However in each group of men some concern was
expressed about the behaviour of the police and potential
misuse of the dried blood spots. Those men who
expressed such concerns demonstrated a clear general lack
of trust in the police. While outlining the current agree-
ment in NSW between police and health authorities
appeared to be reassuring, there was still some continuing
concern expressed among several of the male participants.
Even if the blood spot sample was released initially for
apparently legitimate reasons these men suggested it
might later be used for other illicit purposes including
such as by corrupt police officers to frame an individual.
Scenario four raised the potential use of samples for pater-
nity testing and the involvement of the courts stimulated
some further discussion. The justice system was seen as
the appropriate mechanism through which requests for
access to the specimens in cases such as this should pro-
ceed. A common response was that if the court demanded
access to the dried blood spots for testing, little resistance
could be made.Australia and New Zealand Health Policy 2006, 3:14 http://www.anzhealthpolicy.com/content/3/1/14
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(d) Retention of dried blood spot specimens, ownership and records
A common initial response to learning about the storage
of the dried blood spot specimens was to query how prac-
tical this was and the space requirements it raised. Ques-
tions were raised as to how securely access was controlled
and it was suggested that no system could ever be impen-
etrable to abuse. A number of participants, mostly men,
cited media coverage of the inappropriate use of personal
information by police, other government agencies and
private companies which illustrated how public privacy
concerns had increased in recent years. Privacy concerns
such as identify theft, credit card fraud and problems with
internet security highlighted to them that storing the dried
blood spot specimens raised privacy and security issues.
Several male participants suggested unprompted that the
samples could be used to create a DNA database.
The rationale for the 18 year storage period for the NSW
dried blood spot specimens perplexed several partici-
pants. While several participants suggested that they be
stored for longer, others suggested that the current cut off
was likely explained in some way by the child reaching
maturity and therefore fresh consent might need to be
sought.
A common question posed was why the specimens were
not stored for longer if they had such value for further
medical research. Based on what they had heard and
learnt in the group discussions most were prepared to
accept the existing position of 18 years. No participant
suggested that currently stored dried blood spot speci-
mens should be destroyed prior to the current 18 year
retention period.
Generally ownership of the specimens was not claimed by
participants although they did view that they had some
rights over them and should have some say over how they
were used. A distinction was made by several participants
between the storage of the specimen itself and the records
containing the results derived from testing. They ques-
tioned whether the electronic records were also destroyed
after 18 years.
In the reconvened groups moderators raised the fact that
there were different storage retention policies in different
Australian states. The variation was surprising and unset-
tling for many participants. They had expected that the
NBS policies and issues they were discussing would be
similar across Australia. The fact that the retention periods
differed so significantly led them to question if there was
further information available which might provide a
rational explanation.
Concerns were also expressed if an individual relocated to
another Australian state it may be difficult for them to
access the stored dried blood spot if ever necessary. Such
comments were in the context of the perceived direct per-
sonal benefit from the storage. They questioned in such
cases if it was possible for the specimens to be transferred
between states.
Discussion
Participants in this study had some vague initial under-
standing of the procedures of NBS, yet they knew very lit-
tle about its specific purpose and implications. There
would also seem to be a very low level of community
awareness that the dried blood spots are stored and
indeed many people do not seem to have previously con-
sidered what happens to other biological samples they
have given in health settings.
While the concept of accessing the dried blood spots for
other uses was new to the groups, all quickly understood
the issues and were able to participate in the discussions.
Despite the surprising discovery that these dried blood
spot specimens were kept, there was no evident rush to
demand they should be destroyed because they were una-
ware of their existence. It appeared that this high level of
community trust and support for storage was under-
pinned in part by a misconception that the specimens
could commonly have direct future personal benefit to an
individual. It was evident that when participants were dis-
cussing testing as part of NBS, they were also often consid-
ering that the dried blood spots might be used for
additional tests at a later date in a child's development. In
reality examples of benefits for the family, where they
occur, are in enabling prenatal testing and for forensic
identification.
The support for the use of the dried blood spot specimens
in medical research may be reassuring. All participants
grasped the distinctions between identified and ano-
nymised research and seemed satisfied with the rules and
regulations as they were presented to them. This study
found very high levels of trust in the medical profession
and government regulation. There was very little ques-
tioning of the mechanisms in place to oversee research
upon samples and rather participants were accepting that
if an ethics committee is in place it can be trusted to act in
the public good. There was little evidence of the mistrust
and cynicism with scientists and institutions that has been
described in some European Countries [16].
Support amongst participants for use of dried blood spot
specimens in identifying missing persons was particularly
strong. Linked to this view were the concerns raised by
young people whose specimens had recently been
destroyed about the loss of utility for them in this context.
There was some support in this study for the use of dried
blood spot specimens by police to identify suspects inAustralia and New Zealand Health Policy 2006, 3:14 http://www.anzhealthpolicy.com/content/3/1/14
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criminal cases. Findings from international public surveys
[17] also suggest that many members of the public, at
least in the UK, would express support for this use. While
this general support for access to the cards by the police
indicates that many may view this positively, it was also
very clear that there were a number of participants
strongly objected to access by such third parties. Trust, or
lack thereof, seemed to underpin these views as well as the
experiences of some of the participants, particularly men,
in the use of electronic data. Concerns were also expressed
about the privacy and security of the samples, the possibil-
ity of identity fraud as well as inappropriate use of data
and forensic samples by the police.
Whilst many in the community may have high levels of
trust this is likely to be impacted by critical media cover-
age of a NBS program. In this context it is noteworthy that,
to date, there has been little media coverage, of any form,
related to NBS in NSW. A search, using an online cata-
logue, for recent media articles about NBS revealed almost
nothing in NSW yet several stories raising concerns about
the dried blood spot specimens were found from other
Australian states and also from New Zealand [18,19].
Some health professionals in other Australian states have
suggested that the concerned media and "conspiracy the-
orists" should be reassured by the strict controls that
already exist to protect information [20]. However it is
also clear that it is better to consider and address at the
outset issues which are likely to be sensitive or have the
potential to raise controversy in the community. Once
lost public trust can be very difficult to rebuild and in part
it needs to be maintained by listening to public concerns
seriously, even if they appear at first irrational, and by
considering what underlies them [16].
The qualitative approach used here presents opportunities
for extended discussion, consideration of information
and further deliberation over a few days. It therefore sup-
ports a deeper exploration and understanding of commu-
nity views than some other methodologies. It is evident
from our findings that a quantitative approach, such as
implementing a survey, would be of limited initial value
in engaging these stakeholder groups in policy issues.
Whilst many people would probably give a response to a
survey question, if they do not understand the question
and the background, some responses may simply be 'non-
opinions'.
Public opinion polls and surveys do have a role in inform-
ing health policy development in this area. A recent mail
survey of mothers from Western Australia generally con-
firms the picture we have found in that many parents do
not feel well informed about NBS and storage of the dried
blood spot specimens [21]. Nevertheless the survey find-
ings also highlighted some of the methodological difficul-
ties in engaging consumers and assessing their views.
When asked in the survey, almost one in three mothers
supported the current two year retention for dried blood
spot specimens. However these mothers also noted that
they did not possess adequate knowledge of the issues to
consider any alternative options for retention policies and
therefore supported the status quo as presented to them. It
is in situations such as this that there is significant value
in a more deliberative approach to exploring valid com-
munity views. In contrast to the Western Australian study,
we did not discern broad concern for the extended storage
of the dried blood spots. This significant difference may
reflect the background and experience of the participants
as well as the more deliberative consideration of the issues
enabled by the methodologies used in our study. The
findings from the study presented here provide a basis for
further research exploring any differences in perspectives
of the wider Australian community.
All methodologies which attempt to explore and consider
public attitudes and opinion have their own limitations.
Whilst the qualitative approach used here was designed to
capture a range of different perspectives it does not claim
to present a representative picture of the population's
views. This study included few people from culturally
diverse backgrounds or other groups whose views may be
quite different from those reported. It is worth noting that
several studies in other countries suggest that those from
certain ethnic minority backgrounds are much more likely
to have concerns with the storage of biological samples,
access to genetic databases by third parties and lower level
of trust in health providers [17,22]. We would expect
there to be some further sensitivities towards NBS pro-
grams amongst these and other vulnerable groups.
Furthermore in this study discussions about NBS and
associated issues of storage and further use were framed in
the context of health, testing and screening generally. NBS
was presented to participants in a medical context which
initially highlighted its direct application in detecting rare
and treatable conditions. It was on this canvas that further
discussion was initiated. Many participants seemed to
find it difficult to move beyond the immediate perceived
personal benefits NBS testing and dried blood spot speci-
men storage could offer them.
Genuine community consultation is essential to support
attempts to develop national policy standards especially
in areas which are currently of greatest divergence, notably
the retention and further use of dried blood spot speci-
mens. It will require an understanding of community per-
spectives and their involvement in building a model
which has widespread support. It will also likely require
some further development and testing of appropriate
public involvement methodologies.Australia and New Zealand Health Policy 2006, 3:14 http://www.anzhealthpolicy.com/content/3/1/14
Page 8 of 9
(page number not for citation purposes)
Policy implications and conclusion
This deliberative and consultative process has provided
rich data to inform the development of state and national
policies in NBS. It especially provides a deeper insight into
community views of the retention and storage of dried
blood spot cards. The findings suggest that, with the pro-
vision of information and opportunities for deliberation,
many members of the wider community are likely to sup-
port the extended storage of dried blood spot specimens
and their use in medical research.
The printed materials offered to parents in NSW [8] are
notable in that they explicitly outline that the blood spot
cards are stored and how they may be accessed and used
in the future. However it would seem that many parents
fail to absorb or are aware of this information. In line with
the findings of this study NSW Health NBS policy has
recently been updated and now includes further advice for
health professionals to effectively communicate to par-
ents that the blood spots cards are stored [7].
There is additional evidence that community awareness of
NBS may also be limited in other Australian states [23].
Researchers conducting a community study commis-
sioned by the Victorian Government [24] have suggested
that parents are not given enough information about new-
born screening and that there is a general lack of under-
standing about storage procedures [25]. This research has
informed the development of a policy review which rec-
ommends to the Victorian Minister for Health an
improved community education program and that
extended storage of the blood spot cards should include
explicit written consent from parents [26].
These policy issues potentially have national as well as
state relevance. The consternation expressed amongst
those we spoke to regarding differences in policies for NBS
across Australia supports the current deliberations of the
Australian Health Ministers' Advisory Committee where a
subgroup has been asked by the Commonwealth Govern-
ment to consider the development of national NBS stand-
ards [10]. In our study the different State NBS policies
regarding storage of dried blood spot cards were identified
as a matter of concern that required rationalization. One
aspect participants highlighted was that family members,
often dispersed geographically, should have equitable
access to the perceived benefits in storing the dried blood
spots.
This study demonstrates that members of the wider com-
munity are clearly able to engage and consider some of
complex issues and grasp some of the key scientific, social
and ethical issues raised by developments in genetic
health. These participants were not specialists in health,
policy or ethics yet they were able to contribute unique
perspectives as consumers of genetics services. Those we
spoke to embraced the sometimes challenging and com-
plex issues, considered these carefully and were willing to
share and listen to views of others. They were also willing
to problem solve and make positive suggestions as to how
policies and practices could be further developed. This
bodes well for a more inclusive strategy in the develop-
ment of public policies in the developing field of genetic
heath.
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